Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
HB Cai, MY Zhao, XH Li, YQ Li, TH Yu… - Frontiers in …, 2024 - frontiersin.org
Background We explored the characteristics of single-cell differentiation data in
glioblastoma and established prognostic markers based on CRYAB to predict the prognosis …
glioblastoma and established prognostic markers based on CRYAB to predict the prognosis …
Comprehensive In silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of …
Cholangiocarcinoma (CCA) is a subtype of liver cancer with increasing incidence, poor
prognosis, and limited treatment modalities. It is, therefore, imperative to identify novel …
prognosis, and limited treatment modalities. It is, therefore, imperative to identify novel …
[HTML][HTML] Integrated analysis of-omic landscapes in breast cancer subtypes
S Davitavyan, G Martirosyan, G Mkrtchyan… - …, 2024 - f1000research.com
The subtypes of breast cancer exhibit diverse histology, molecular features, therapeutic
response, aggressiveness, and patient outcomes. Multi-omics high-throughput technologies …
response, aggressiveness, and patient outcomes. Multi-omics high-throughput technologies …
Expressão de marcadores tumorais CRYAB e VEGF em hemangiossarcomas caninos e sua relação com o grau histológico
NM Figueiredo - 2023 - locus.ufv.br
Os sarcomas de tecidos moles (STM) são neoplasias malignas que surgem de diferentes
tipos de tecido conjuntivo e células do endotélio vascular. Eles são classificados em STM …
tipos de tecido conjuntivo e células do endotélio vascular. Eles são classificados em STM …
Characterizing the Underlying Biology of Glioblastoma Tumors Through Omics Technology
E Lewis - 2024 - search.proquest.com
Glioblastoma multiforme (GBM) is an aggressive, high-grade glioma for which available
treatments produce limited success. The lack of effective GBM therapies stems from …
treatments produce limited success. The lack of effective GBM therapies stems from …